Dupont Capital Management’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-2,997
Closed -$291K – 1658
2022
Q2
$291K Hold
2,997
– – 0.01% 864
2022
Q1
$337K Sell
2,997
-2,173
-42% -$232K 0.01% 894
2021
Q4
$698K Buy
+5,170
New +$720K 0.02% 674
2021
Q3
– Sell
-4,130
Closed -$529K – 1803
2021
Q2
$529K Sell
4,130
-3,724
-47% -$438K 0.01% 939
2021
Q1
$1M Buy
7,854
+4,662
+146% +$861K 0.02% 570
2020
Q4
$573K Sell
3,192
-3,392
-52% -$754K 0.01% 793
2020
Q3
$1.44M Buy
6,584
+3,657
+125% +$816K 0.03% 389
2020
Q2
$655K Buy
+2,927
New +$459K 0.01% 653
2019
Q2
– Sell
-7,045
Closed -$461K – 1257
2019
Q1
$461K Hold
7,045
– – 0.01% 782
2018
Q4
$344K Buy
7,045
+1,400
+25% +$83.6K 0.01% 867
2018
Q3
$368K Hold
5,645
– – 0.01% 785
2018
Q2
$375K Sell
5,645
-25,466
-82% -$1.54M 0.01% 776
2018
Q1
$1.61M Hold
31,111
– – 0.04% 392
2017
Q4
$1.35M Sell
31,111
-9,312
-23% -$381K 0.03% 450
2017
Q3
$1.77M Sell
40,423
-26,954
-40% -$938K 0.04% 393
2017
Q2
$1.83M Buy
+67,377
New +$1.67M 0.04% 384

Other funds holding QDEL

Dupont Capital Management's QDEL Position: Q3 2022 in Review

Dupont Capital Management sold out of QuidelOrtho (QDEL) in Q3 2022, closing a stake of 2,997 shares — an estimated $291K sold.

Dupont Capital Management first reported a position in QDEL in Q2 2017 and held it in 16 quarters. The position peaked at $1.83M in Q2 2017. 315 funds tracked by Wall St. Rank hold QDEL as of Q3 2022.

  • Dupont Capital Management reported no remaining QuidelOrtho position as of Q3 2022 after selling out during the quarter.
  • Dupont Capital Management sold 2,997 QuidelOrtho shares in Q3 2022, an estimated $291K.
  • Dupont Capital Management first reported a position in QuidelOrtho in Q2 2017 and held it in 16 quarters.
  • Dupont Capital Management's QuidelOrtho position peaked at $1.83M in Q2 2017.
  • 315 funds tracked by Wall St. Rank held QuidelOrtho as of Q3 2022.

Based on Dupont Capital Management's 13F filing for Q3 2022, filed 31 Oct 2022.